Diabetes patients tested: does daily aspirin actually work?
NCT ID NCT05105919
Summary
This early study aims to understand how well daily low-dose aspirin prevents blood clotting in people with type 2 diabetes. Researchers will give 50 participants aspirin for 7 days and measure their blood's clotting response before and after treatment. The goal is to gather preliminary data to plan a larger future trial, not to treat or cure diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Conditions
Explore the condition pages connected to this study.